1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global RNAi Technologies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Oncology
        1.2.3 Ocular Disorders
        1.2.4 Respiratory Disorders
        1.2.5 Liver Diseases
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global RNAi Technologies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Research
        1.3.3 Therapeutics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global RNAi Technologies Market Perspective (2017-2028)
    2.2 RNAi Technologies Growth Trends by Region
        2.2.1 RNAi Technologies Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 RNAi Technologies Historic Market Size by Region (2017-2022)
        2.2.3 RNAi Technologies Forecasted Market Size by Region (2023-2028)
    2.3 RNAi Technologies Market Dynamics
        2.3.1 RNAi Technologies Industry Trends
        2.3.2 RNAi Technologies Market Drivers
        2.3.3 RNAi Technologies Market Challenges
        2.3.4 RNAi Technologies Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top RNAi Technologies Players by Revenue
        3.1.1 Global Top RNAi Technologies Players by Revenue (2017-2022)
        3.1.2 Global RNAi Technologies Revenue Market Share by Players (2017-2022)
    3.2 Global RNAi Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by RNAi Technologies Revenue
    3.4 Global RNAi Technologies Market Concentration Ratio
        3.4.1 Global RNAi Technologies Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by RNAi Technologies Revenue in 2021
    3.5 RNAi Technologies Key Players Head office and Area Served
    3.6 Key Players RNAi Technologies Product Solution and Service
    3.7 Date of Enter into RNAi Technologies Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 RNAi Technologies Breakdown Data by Type
    4.1 Global RNAi Technologies Historic Market Size by Type (2017-2022)
    4.2 Global RNAi Technologies Forecasted Market Size by Type (2023-2028)
5 RNAi Technologies Breakdown Data by Application
    5.1 Global RNAi Technologies Historic Market Size by Application (2017-2022)
    5.2 Global RNAi Technologies Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America RNAi Technologies Market Size (2017-2028)
    6.2 North America RNAi Technologies Market Size by Type
        6.2.1 North America RNAi Technologies Market Size by Type (2017-2022)
        6.2.2 North America RNAi Technologies Market Size by Type (2023-2028)
        6.2.3 North America RNAi Technologies Market Share by Type (2017-2028)
    6.3 North America RNAi Technologies Market Size by Application
        6.3.1 North America RNAi Technologies Market Size by Application (2017-2022)
        6.3.2 North America RNAi Technologies Market Size by Application (2023-2028)
        6.3.3 North America RNAi Technologies Market Share by Application (2017-2028)
    6.4 North America RNAi Technologies Market Size by Country
        6.4.1 North America RNAi Technologies Market Size by Country (2017-2022)
        6.4.2 North America RNAi Technologies Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe RNAi Technologies Market Size (2017-2028)
    7.2 Europe RNAi Technologies Market Size by Type
        7.2.1 Europe RNAi Technologies Market Size by Type (2017-2022)
        7.2.2 Europe RNAi Technologies Market Size by Type (2023-2028)
        7.2.3 Europe RNAi Technologies Market Share by Type (2017-2028)
    7.3 Europe RNAi Technologies Market Size by Application
        7.3.1 Europe RNAi Technologies Market Size by Application (2017-2022)
        7.3.2 Europe RNAi Technologies Market Size by Application (2023-2028)
        7.3.3 Europe RNAi Technologies Market Share by Application (2017-2028)
    7.4 Europe RNAi Technologies Market Size by Country
        7.4.1 Europe RNAi Technologies Market Size by Country (2017-2022)
        7.4.2 Europe RNAi Technologies Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific RNAi Technologies Market Size (2017-2028)
    8.2 Asia-Pacific RNAi Technologies Market Size by Type
        8.2.1 Asia-Pacific RNAi Technologies Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific RNAi Technologies Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific RNAi Technologies Market Share by Type (2017-2028)
    8.3 Asia-Pacific RNAi Technologies Market Size by Application
        8.3.1 Asia-Pacific RNAi Technologies Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific RNAi Technologies Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific RNAi Technologies Market Share by Application (2017-2028)
    8.4 Asia-Pacific RNAi Technologies Market Size by Region
        8.4.1 Asia-Pacific RNAi Technologies Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific RNAi Technologies Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America RNAi Technologies Market Size (2017-2028)
    9.2 Latin America RNAi Technologies Market Size by Type
        9.2.1 Latin America RNAi Technologies Market Size by Type (2017-2022)
        9.2.2 Latin America RNAi Technologies Market Size by Type (2023-2028)
        9.2.3 Latin America RNAi Technologies Market Share by Type (2017-2028)
    9.3 Latin America RNAi Technologies Market Size by Application
        9.3.1 Latin America RNAi Technologies Market Size by Application (2017-2022)
        9.3.2 Latin America RNAi Technologies Market Size by Application (2023-2028)
        9.3.3 Latin America RNAi Technologies Market Share by Application (2017-2028)
    9.4 Latin America RNAi Technologies Market Size by Country
        9.4.1 Latin America RNAi Technologies Market Size by Country (2017-2022)
        9.4.2 Latin America RNAi Technologies Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa RNAi Technologies Market Size (2017-2028)
    10.2 Middle East & Africa RNAi Technologies Market Size by Type
        10.2.1 Middle East & Africa RNAi Technologies Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa RNAi Technologies Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa RNAi Technologies Market Share by Type (2017-2028)
    10.3 Middle East & Africa RNAi Technologies Market Size by Application
        10.3.1 Middle East & Africa RNAi Technologies Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa RNAi Technologies Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa RNAi Technologies Market Share by Application (2017-2028)
    10.4 Middle East & Africa RNAi Technologies Market Size by Country
        10.4.1 Middle East & Africa RNAi Technologies Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa RNAi Technologies Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Alnylam Pharmaceuticals
        11.1.1 Alnylam Pharmaceuticals Company Details
        11.1.2 Alnylam Pharmaceuticals Business Overview
        11.1.3 Alnylam Pharmaceuticals RNAi Technologies Introduction
        11.1.4 Alnylam Pharmaceuticals Revenue in RNAi Technologies Business (2017-2022)
        11.1.5 Alnylam Pharmaceuticals Recent Developments
    11.2 Benitec Biopharma Ltd
        11.2.1 Benitec Biopharma Ltd Company Details
        11.2.2 Benitec Biopharma Ltd Business Overview
        11.2.3 Benitec Biopharma Ltd RNAi Technologies Introduction
        11.2.4 Benitec Biopharma Ltd Revenue in RNAi Technologies Business (2017-2022)
        11.2.5 Benitec Biopharma Ltd Recent Developments
    11.3 Filmtec Corporation
        11.3.1 Filmtec Corporation Company Details
        11.3.2 Filmtec Corporation Business Overview
        11.3.3 Filmtec Corporation RNAi Technologies Introduction
        11.3.4 Filmtec Corporation Revenue in RNAi Technologies Business (2017-2022)
        11.3.5 Filmtec Corporation Recent Developments
    11.4 Ionis Pharmaceuticals
        11.4.1 Ionis Pharmaceuticals Company Details
        11.4.2 Ionis Pharmaceuticals Business Overview
        11.4.3 Ionis Pharmaceuticals RNAi Technologies Introduction
        11.4.4 Ionis Pharmaceuticals Revenue in RNAi Technologies Business (2017-2022)
        11.4.5 Ionis Pharmaceuticals Recent Developments
    11.5 Quark Pharmaceuticals Inc.
        11.5.1 Quark Pharmaceuticals Inc. Company Details
        11.5.2 Quark Pharmaceuticals Inc. Business Overview
        11.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Introduction
        11.5.4 Quark Pharmaceuticals Inc. Revenue in RNAi Technologies Business (2017-2022)
        11.5.5 Quark Pharmaceuticals Inc. Recent Developments
    11.6 RXI Pharmaceuticals
        11.6.1 RXI Pharmaceuticals Company Details
        11.6.2 RXI Pharmaceuticals Business Overview
        11.6.3 RXI Pharmaceuticals RNAi Technologies Introduction
        11.6.4 RXI Pharmaceuticals Revenue in RNAi Technologies Business (2017-2022)
        11.6.5 RXI Pharmaceuticals Recent Developments
    11.7 Qiagen
        11.7.1 Qiagen Company Details
        11.7.2 Qiagen Business Overview
        11.7.3 Qiagen RNAi Technologies Introduction
        11.7.4 Qiagen Revenue in RNAi Technologies Business (2017-2022)
        11.7.5 Qiagen Recent Developments
    11.8 Invitrogen
        11.8.1 Invitrogen Company Details
        11.8.2 Invitrogen Business Overview
        11.8.3 Invitrogen RNAi Technologies Introduction
        11.8.4 Invitrogen Revenue in RNAi Technologies Business (2017-2022)
        11.8.5 Invitrogen Recent Developments
    11.9 Ambion
        11.9.1 Ambion Company Details
        11.9.2 Ambion Business Overview
        11.9.3 Ambion RNAi Technologies Introduction
        11.9.4 Ambion Revenue in RNAi Technologies Business (2017-2022)
        11.9.5 Ambion Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global RNAi Technologies Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Oncology
    Table 3. Key Players of Ocular Disorders
    Table 4. Key Players of Respiratory Disorders
    Table 5. Key Players of Liver Diseases
    Table 6. Key Players of Other
    Table 7. Global RNAi Technologies Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global RNAi Technologies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global RNAi Technologies Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global RNAi Technologies Market Share by Region (2017-2022)
    Table 11. Global RNAi Technologies Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global RNAi Technologies Market Share by Region (2023-2028)
    Table 13. RNAi Technologies Market Trends
    Table 14. RNAi Technologies Market Drivers
    Table 15. RNAi Technologies Market Challenges
    Table 16. RNAi Technologies Market Restraints
    Table 17. Global RNAi Technologies Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global RNAi Technologies Revenue Share by Players (2017-2022)
    Table 19. Global Top RNAi Technologies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Technologies as of 2021)
    Table 20. Ranking of Global Top RNAi Technologies Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by RNAi Technologies Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players RNAi Technologies Product Solution and Service
    Table 24. Date of Enter into RNAi Technologies Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global RNAi Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global RNAi Technologies Revenue Market Share by Type (2017-2022)
    Table 28. Global RNAi Technologies Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global RNAi Technologies Revenue Market Share by Type (2023-2028)
    Table 30. Global RNAi Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global RNAi Technologies Revenue Share by Application (2017-2022)
    Table 32. Global RNAi Technologies Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global RNAi Technologies Revenue Share by Application (2023-2028)
    Table 34. North America RNAi Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America RNAi Technologies Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America RNAi Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America RNAi Technologies Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America RNAi Technologies Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America RNAi Technologies Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe RNAi Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe RNAi Technologies Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe RNAi Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe RNAi Technologies Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe RNAi Technologies Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe RNAi Technologies Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific RNAi Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific RNAi Technologies Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific RNAi Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific RNAi Technologies Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific RNAi Technologies Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific RNAi Technologies Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America RNAi Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America RNAi Technologies Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America RNAi Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America RNAi Technologies Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America RNAi Technologies Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America RNAi Technologies Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa RNAi Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa RNAi Technologies Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa RNAi Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa RNAi Technologies Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa RNAi Technologies Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa RNAi Technologies Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Alnylam Pharmaceuticals Company Details
    Table 65. Alnylam Pharmaceuticals Business Overview
    Table 66. Alnylam Pharmaceuticals RNAi Technologies Product
    Table 67. Alnylam Pharmaceuticals Revenue in RNAi Technologies Business (2017-2022) & (US$ Million)
    Table 68. Alnylam Pharmaceuticals Recent Developments
    Table 69. Benitec Biopharma Ltd Company Details
    Table 70. Benitec Biopharma Ltd Business Overview
    Table 71. Benitec Biopharma Ltd RNAi Technologies Product
    Table 72. Benitec Biopharma Ltd Revenue in RNAi Technologies Business (2017-2022) & (US$ Million)
    Table 73. Benitec Biopharma Ltd Recent Developments
    Table 74. Filmtec Corporation Company Details
    Table 75. Filmtec Corporation Business Overview
    Table 76. Filmtec Corporation RNAi Technologies Product
    Table 77. Filmtec Corporation Revenue in RNAi Technologies Business (2017-2022) & (US$ Million)
    Table 78. Filmtec Corporation Recent Developments
    Table 79. Ionis Pharmaceuticals Company Details
    Table 80. Ionis Pharmaceuticals Business Overview
    Table 81. Ionis Pharmaceuticals RNAi Technologies Product
    Table 82. Ionis Pharmaceuticals Revenue in RNAi Technologies Business (2017-2022) & (US$ Million)
    Table 83. Ionis Pharmaceuticals Recent Developments
    Table 84. Quark Pharmaceuticals Inc. Company Details
    Table 85. Quark Pharmaceuticals Inc. Business Overview
    Table 86. Quark Pharmaceuticals Inc. RNAi Technologies Product
    Table 87. Quark Pharmaceuticals Inc. Revenue in RNAi Technologies Business (2017-2022) & (US$ Million)
    Table 88. Quark Pharmaceuticals Inc. Recent Developments
    Table 89. RXI Pharmaceuticals Company Details
    Table 90. RXI Pharmaceuticals Business Overview
    Table 91. RXI Pharmaceuticals RNAi Technologies Product
    Table 92. RXI Pharmaceuticals Revenue in RNAi Technologies Business (2017-2022) & (US$ Million)
    Table 93. RXI Pharmaceuticals Recent Developments
    Table 94. Qiagen Company Details
    Table 95. Qiagen Business Overview
    Table 96. Qiagen RNAi Technologies Product
    Table 97. Qiagen Revenue in RNAi Technologies Business (2017-2022) & (US$ Million)
    Table 98. Qiagen Recent Developments
    Table 99. Invitrogen Company Details
    Table 100. Invitrogen Business Overview
    Table 101. Invitrogen RNAi Technologies Product
    Table 102. Invitrogen Revenue in RNAi Technologies Business (2017-2022) & (US$ Million)
    Table 103. Invitrogen Recent Developments
    Table 104. Ambion Company Details
    Table 105. Ambion Business Overview
    Table 106. Ambion RNAi Technologies Product
    Table 107. Ambion Revenue in RNAi Technologies Business (2017-2022) & (US$ Million)
    Table 108. Ambion Recent Developments
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global RNAi Technologies Market Share by Type: 2021 VS 2028
    Figure 2. Oncology Features
    Figure 3. Ocular Disorders Features
    Figure 4. Respiratory Disorders Features
    Figure 5. Liver Diseases Features
    Figure 6. Other Features
    Figure 7. Global RNAi Technologies Market Share by Application: 2021 VS 2028
    Figure 8. Research Case Studies
    Figure 9. Therapeutics Case Studies
    Figure 10. RNAi Technologies Report Years Considered
    Figure 11. Global RNAi Technologies Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global RNAi Technologies Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global RNAi Technologies Market Share by Region: 2021 VS 2028
    Figure 14. Global RNAi Technologies Market Share by Players in 2021
    Figure 15. Global Top RNAi Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Technologies as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by RNAi Technologies Revenue in 2021
    Figure 17. North America RNAi Technologies Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America RNAi Technologies Market Size Market Share by Type (2017-2028)
    Figure 19. North America RNAi Technologies Market Size Market Share by Application (2017-2028)
    Figure 20. North America RNAi Technologies Market Size Share by Country (2017-2028)
    Figure 21. United States RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe RNAi Technologies Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe RNAi Technologies Market Size Market Share by Type (2017-2028)
    Figure 25. Europe RNAi Technologies Market Size Market Share by Application (2017-2028)
    Figure 26. Europe RNAi Technologies Market Size Share by Country (2017-2028)
    Figure 27. Germany RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific RNAi Technologies Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific RNAi Technologies Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific RNAi Technologies Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific RNAi Technologies Market Size Share by Region (2017-2028)
    Figure 37. China RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America RNAi Technologies Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America RNAi Technologies Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America RNAi Technologies Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America RNAi Technologies Market Size Share by Country (2017-2028)
    Figure 47. Mexico RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa RNAi Technologies Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa RNAi Technologies Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa RNAi Technologies Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa RNAi Technologies Market Size Share by Country (2017-2028)
    Figure 53. Turkey RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE RNAi Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Alnylam Pharmaceuticals Revenue Growth Rate in RNAi Technologies Business (2017-2022)
    Figure 57. Benitec Biopharma Ltd Revenue Growth Rate in RNAi Technologies Business (2017-2022)
    Figure 58. Filmtec Corporation Revenue Growth Rate in RNAi Technologies Business (2017-2022)
    Figure 59. Ionis Pharmaceuticals Revenue Growth Rate in RNAi Technologies Business (2017-2022)
    Figure 60. Quark Pharmaceuticals Inc. Revenue Growth Rate in RNAi Technologies Business (2017-2022)
    Figure 61. RXI Pharmaceuticals Revenue Growth Rate in RNAi Technologies Business (2017-2022)
    Figure 62. Qiagen Revenue Growth Rate in RNAi Technologies Business (2017-2022)
    Figure 63. Invitrogen Revenue Growth Rate in RNAi Technologies Business (2017-2022)
    Figure 64. Ambion Revenue Growth Rate in RNAi Technologies Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed